

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chronic inflammatory response (GO:0002676) | 5.69414236 |
| 2 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.62838473 |
| 3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.27503345 |
| 4 | regulation of fever generation (GO:0031620) | 5.25129728 |
| 5 | positive regulation of heat generation (GO:0031652) | 5.19010088 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 5.13689043 |
| 7 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.94571406 |
| 8 | response to interferon-beta (GO:0035456) | 4.70310401 |
| 9 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.68465630 |
| 10 | regulation of growth of symbiont in host (GO:0044126) | 4.68465630 |
| 11 | negative regulation of growth of symbiont in host (GO:0044130) | 4.68465630 |
| 12 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.68465630 |
| 13 | hemidesmosome assembly (GO:0031581) | 4.53116412 |
| 14 | neutrophil mediated immunity (GO:0002446) | 4.36650388 |
| 15 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.34073011 |
| 16 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.30345050 |
| 17 | cellular response to interferon-beta (GO:0035458) | 4.22511499 |
| 18 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.21254580 |
| 19 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.14769954 |
| 20 | adhesion of symbiont to host cell (GO:0044650) | 4.08436474 |
| 21 | virion attachment to host cell (GO:0019062) | 4.08436474 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.03357596 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.99410072 |
| 24 | regulation of podosome assembly (GO:0071801) | 3.96962409 |
| 25 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.95408430 |
| 26 | reactive oxygen species biosynthetic process (GO:1903409) | 3.94192646 |
| 27 | regulation of immunoglobulin secretion (GO:0051023) | 3.92648282 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.89821742 |
| 29 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.88838056 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85345311 |
| 31 | myeloid leukocyte mediated immunity (GO:0002444) | 3.84429946 |
| 32 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.76742721 |
| 33 | cellular response to zinc ion (GO:0071294) | 3.75190363 |
| 34 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.74525588 |
| 35 | regulation of heat generation (GO:0031650) | 3.72955703 |
| 36 | DNA deamination (GO:0045006) | 3.68820030 |
| 37 | regulation of mononuclear cell migration (GO:0071675) | 3.68470311 |
| 38 | response to peptidoglycan (GO:0032494) | 3.66220522 |
| 39 | activation of MAPKKK activity (GO:0000185) | 3.64021453 |
| 40 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.59913152 |
| 41 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.59913152 |
| 42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.59655604 |
| 43 | negative regulation of phagocytosis (GO:0050765) | 3.58931760 |
| 44 | adhesion of symbiont to host (GO:0044406) | 3.52890358 |
| 45 | regulation of chemokine biosynthetic process (GO:0045073) | 3.48533658 |
| 46 | positive regulation of type 2 immune response (GO:0002830) | 3.46924619 |
| 47 | response to interferon-alpha (GO:0035455) | 3.46687397 |
| 48 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.45977574 |
| 49 | positive regulation of p38MAPK cascade (GO:1900745) | 3.42925704 |
| 50 | positive regulation of acute inflammatory response (GO:0002675) | 3.34912017 |
| 51 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.30273805 |
| 52 | negative regulation of amino acid transport (GO:0051956) | 3.29562754 |
| 53 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.28018470 |
| 54 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.27415596 |
| 55 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.27415596 |
| 56 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.27387911 |
| 57 | positive regulation of interleukin-6 production (GO:0032755) | 3.26309496 |
| 58 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.25656945 |
| 59 | cellular response to lipopolysaccharide (GO:0071222) | 3.24257985 |
| 60 | response to fungus (GO:0009620) | 3.22100001 |
| 61 | cell adhesion mediated by integrin (GO:0033627) | 3.18960646 |
| 62 | viral transcription (GO:0019083) | 3.16012112 |
| 63 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.15843459 |
| 64 | negative regulation of viral genome replication (GO:0045071) | 3.15772472 |
| 65 | regulation of T-helper cell differentiation (GO:0045622) | 3.14759563 |
| 66 | cellular response to interferon-alpha (GO:0035457) | 3.14112975 |
| 67 | response to UV-B (GO:0010224) | 3.13956443 |
| 68 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.12961527 |
| 69 | cellular response to nicotine (GO:0071316) | 3.12622464 |
| 70 | regulation of activation of Janus kinase activity (GO:0010533) | 3.12090280 |
| 71 | negative regulation of lipid storage (GO:0010888) | 3.10961329 |
| 72 | chronic inflammatory response (GO:0002544) | 3.10527812 |
| 73 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.10023197 |
| 74 | cellular response to molecule of bacterial origin (GO:0071219) | 3.07224914 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 3.06173444 |
| 76 | cotranslational protein targeting to membrane (GO:0006613) | 3.05371925 |
| 77 | regulation of type 2 immune response (GO:0002828) | 3.05093713 |
| 78 | protein targeting to ER (GO:0045047) | 3.04734509 |
| 79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.03612165 |
| 80 | translational termination (GO:0006415) | 3.01883987 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 3.00248815 |
| 82 | oligosaccharide catabolic process (GO:0009313) | 2.98739296 |
| 83 | glycosphingolipid catabolic process (GO:0046479) | 2.98443366 |
| 84 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.96997708 |
| 85 | cell differentiation involved in metanephros development (GO:0072202) | 2.94829568 |
| 86 | ovulation (GO:0030728) | 2.94675257 |
| 87 | respiratory burst (GO:0045730) | 2.94664103 |
| 88 | definitive hemopoiesis (GO:0060216) | 2.94486766 |
| 89 | fibril organization (GO:0097435) | 2.94434036 |
| 90 | monocyte chemotaxis (GO:0002548) | 2.94071308 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.91612117 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 2.90277802 |
| 93 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.90057260 |
| 94 | germinal center formation (GO:0002467) | 2.88686956 |
| 95 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.87351193 |
| 96 | protein localization to endoplasmic reticulum (GO:0070972) | 2.86980288 |
| 97 | regulation of vitamin metabolic process (GO:0030656) | 2.86918967 |
| 98 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.86368502 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 2.86306710 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.86306710 |
| 101 | tryptophan catabolic process (GO:0006569) | 2.86306710 |
| 102 | fibrinolysis (GO:0042730) | 2.86083892 |
| 103 | positive regulation of natural killer cell activation (GO:0032816) | 2.85358021 |
| 104 | defense response to protozoan (GO:0042832) | 2.83634469 |
| 105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81067396 |
| 106 | myeloid dendritic cell activation (GO:0001773) | 2.80369420 |
| 107 | respiratory tube development (GO:0030323) | 2.78617084 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77402800 |
| 109 | T-helper 1 type immune response (GO:0042088) | 2.76641954 |
| 110 | positive regulation of chemokine secretion (GO:0090197) | 2.74950506 |
| 111 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.74814745 |
| 112 | decidualization (GO:0046697) | 2.72717350 |
| 113 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.72678343 |
| 114 | polyketide metabolic process (GO:0030638) | 2.71380899 |
| 115 | doxorubicin metabolic process (GO:0044598) | 2.71380899 |
| 116 | daunorubicin metabolic process (GO:0044597) | 2.71380899 |
| 117 | natural killer cell activation involved in immune response (GO:0002323) | 2.70741305 |
| 118 | type I interferon signaling pathway (GO:0060337) | 2.70189081 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.70189081 |
| 120 | macrophage activation involved in immune response (GO:0002281) | 2.69517379 |
| 121 | ribosomal small subunit biogenesis (GO:0042274) | 2.69076051 |
| 122 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.68306864 |
| 123 | superoxide anion generation (GO:0042554) | 2.67894616 |
| 124 | regulation of interleukin-6 production (GO:0032675) | 2.67429223 |
| 125 | response to type I interferon (GO:0034340) | 2.66667658 |
| 126 | kynurenine metabolic process (GO:0070189) | 2.65908506 |
| 127 | positive regulation of interferon-alpha production (GO:0032727) | 2.65576044 |
| 128 | positive regulation of chemokine production (GO:0032722) | 2.64359379 |
| 129 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.63341669 |
| 130 | positive regulation of lipid storage (GO:0010884) | 2.63241046 |
| 131 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.61891265 |
| 132 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.61655287 |
| 133 | cellular response to biotic stimulus (GO:0071216) | 2.61412383 |
| 134 | regulation of interleukin-12 production (GO:0032655) | 2.61377567 |
| 135 | glycolipid catabolic process (GO:0019377) | 2.61026850 |
| 136 | response to protozoan (GO:0001562) | 2.60952509 |
| 137 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60659124 |
| 138 | dendritic cell differentiation (GO:0097028) | 2.60049906 |
| 139 | translational elongation (GO:0006414) | 2.60043650 |
| 140 | extracellular fibril organization (GO:0043206) | 2.59419318 |
| 141 | megakaryocyte development (GO:0035855) | 2.59271770 |
| 142 | response to ATP (GO:0033198) | 2.58624061 |
| 143 | negative regulation of interleukin-8 production (GO:0032717) | 2.57076697 |
| 144 | desmosome organization (GO:0002934) | 2.57043965 |
| 145 | barbed-end actin filament capping (GO:0051016) | 2.56876175 |
| 146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.56580137 |
| 147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.56580137 |
| 148 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56072412 |
| 149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54997159 |
| 150 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53750137 |
| 151 | sequestering of actin monomers (GO:0042989) | 2.52450972 |
| 152 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.51332527 |
| 153 | negative regulation of mast cell activation (GO:0033004) | 2.50616570 |
| 154 | positive regulation of defense response to virus by host (GO:0002230) | 2.50319778 |
| 155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50302427 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49554523 |
| 157 | detection of molecule of bacterial origin (GO:0032490) | 2.48303249 |
| 158 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.48005851 |
| 159 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.46870488 |
| 160 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46840910 |
| 161 | regulation of RIG-I signaling pathway (GO:0039535) | 2.46229168 |
| 162 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.45549267 |
| 163 | positive regulation of interleukin-17 production (GO:0032740) | 2.45020502 |
| 164 | regulation of interferon-alpha production (GO:0032647) | 2.44568709 |
| 165 | mesodermal cell differentiation (GO:0048333) | 2.42549192 |
| 166 | regulation of T-helper 1 type immune response (GO:0002825) | 2.40553180 |
| 167 | myeloid dendritic cell differentiation (GO:0043011) | 2.39278062 |
| 168 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.37902993 |
| 169 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.37869415 |
| 170 | granulocyte activation (GO:0036230) | 2.37814243 |
| 171 | positive regulation of macrophage differentiation (GO:0045651) | 2.37767143 |
| 172 | signal peptide processing (GO:0006465) | 2.37096558 |
| 173 | eosinophil chemotaxis (GO:0048245) | 2.37080801 |
| 174 | kinetochore organization (GO:0051383) | 2.36185407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.35477117 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.58187827 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21539679 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.99458917 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.86286522 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.64163135 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37275995 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.17533219 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02088478 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81906998 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.71766436 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.70602574 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.64801724 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.58822189 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50633435 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49087410 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42682336 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39550259 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36107999 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31900909 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.31384503 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30144414 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.27188405 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23815232 |
| 25 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23599711 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21359648 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18748106 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18372346 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15925312 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15667543 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14044030 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.01282941 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96269998 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.91627859 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91111033 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.89659470 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.87736780 |
| 38 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86009425 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85874720 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84496965 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77171762 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76001531 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74697413 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74055483 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73344662 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73240926 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72524513 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71684681 |
| 49 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71154838 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.70846059 |
| 51 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68383381 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68359476 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67479307 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60426569 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59824040 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.59417484 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58909665 |
| 58 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58576011 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58360970 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57710609 |
| 61 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.56924201 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54004012 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53975996 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53933121 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53558107 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53515504 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52926313 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51334932 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.51132132 |
| 70 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.47512178 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46499050 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45622412 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44113649 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43554925 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43543698 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42699505 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42065315 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41425401 |
| 79 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37968903 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36717681 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35560787 |
| 82 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34956730 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34803006 |
| 84 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34803006 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32852204 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31926017 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31851625 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.27628688 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25296505 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24273965 |
| 91 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22863062 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22626796 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22369595 |
| 94 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21722057 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20598461 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 1.20591247 |
| 97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20167083 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17952816 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17312391 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15397142 |
| 101 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15175730 |
| 102 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14920928 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13517046 |
| 104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13131025 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12268785 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.11515152 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09891482 |
| 108 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.09070326 |
| 109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09011478 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08319155 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07997102 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 1.06930051 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04617613 |
| 114 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.03954088 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.03506365 |
| 116 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.03506365 |
| 117 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.03506365 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03385220 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03019609 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02773891 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02347618 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02272096 |
| 123 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01333041 |
| 124 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01284699 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99844910 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99818193 |
| 127 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99017019 |
| 128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98451663 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97651055 |
| 130 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97551030 |
| 131 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97256882 |
| 132 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96670232 |
| 133 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96663903 |
| 134 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96251499 |
| 135 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95906128 |
| 136 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95483251 |
| 137 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95318686 |
| 138 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95225421 |
| 139 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.94409234 |
| 140 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94319464 |
| 141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91598349 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89166030 |
| 143 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86918824 |
| 144 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86596625 |
| 145 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85234697 |
| 146 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85073332 |
| 147 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84666807 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83813885 |
| 149 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83317521 |
| 150 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82725250 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81793341 |
| 152 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80113769 |
| 153 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80113769 |
| 154 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79529578 |
| 155 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77973973 |
| 156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77487077 |
| 157 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77296036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 4.26236127 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.63025282 |
| 3 | MP0009785_altered_susceptibility_to | 3.39376090 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.16822837 |
| 5 | MP0003436_decreased_susceptibility_to | 3.16313479 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.15517210 |
| 7 | MP0003724_increased_susceptibility_to | 3.12428553 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.97091581 |
| 9 | MP0002006_tumorigenesis | 2.96494088 |
| 10 | MP0005275_abnormal_skin_tensile | 2.96437958 |
| 11 | MP0008004_abnormal_stomach_pH | 2.88489449 |
| 12 | MP0005451_abnormal_body_composition | 2.67373237 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.66162365 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.59694621 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.52568677 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.50991974 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.50867476 |
| 18 | MP0002419_abnormal_innate_immunity | 2.35158869 |
| 19 | MP0005025_abnormal_response_to | 2.26749997 |
| 20 | MP0005410_abnormal_fertilization | 2.26302255 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.22880828 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 2.22569183 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.21146054 |
| 24 | MP0009840_abnormal_foam_cell | 2.17720006 |
| 25 | MP0002254_reproductive_system_inflammat | 2.14784978 |
| 26 | MP0002060_abnormal_skin_morphology | 2.09242350 |
| 27 | MP0008007_abnormal_cellular_replicative | 2.03699388 |
| 28 | MP0000685_abnormal_immune_system | 2.03085853 |
| 29 | MP0005671_abnormal_response_to | 1.93962789 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.92451409 |
| 31 | MP0002009_preneoplasia | 1.91916355 |
| 32 | MP0001853_heart_inflammation | 1.84172189 |
| 33 | MP0003303_peritoneal_inflammation | 1.83460640 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.76632922 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.72065734 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.72065734 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.71373613 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.68916067 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.68155815 |
| 40 | MP0001542_abnormal_bone_strength | 1.67509709 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.65952799 |
| 42 | MP0003195_calcinosis | 1.63078113 |
| 43 | MP0003828_pulmonary_edema | 1.62843879 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.58659368 |
| 45 | MP0000858_altered_metastatic_potential | 1.56564887 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.55168972 |
| 47 | MP0002723_abnormal_immune_serum | 1.54703517 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.52032440 |
| 49 | MP0001819_abnormal_immune_cell | 1.51241653 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.50567741 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.49856994 |
| 52 | MP0002132_abnormal_respiratory_system | 1.49577098 |
| 53 | MP0006082_CNS_inflammation | 1.49458369 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.49091764 |
| 55 | MP0003646_muscle_fatigue | 1.48950325 |
| 56 | MP0001851_eye_inflammation | 1.46638169 |
| 57 | MP0006054_spinal_hemorrhage | 1.44523704 |
| 58 | MP0001800_abnormal_humoral_immune | 1.41148816 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.40178092 |
| 60 | MP0009278_abnormal_bone_marrow | 1.39647625 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.36619451 |
| 62 | MP0003091_abnormal_cell_migration | 1.34246337 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.31977594 |
| 64 | MP0005390_skeleton_phenotype | 1.31396649 |
| 65 | MP0000343_altered_response_to | 1.29402511 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.29129332 |
| 67 | MP0005165_increased_susceptibility_to | 1.26701692 |
| 68 | MP0009764_decreased_sensitivity_to | 1.24987537 |
| 69 | MP0005023_abnormal_wound_healing | 1.23186654 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.22820797 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 1.22687419 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.22105657 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.21106456 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.15357694 |
| 75 | MP0009697_abnormal_copulation | 1.14792639 |
| 76 | MP0001346_abnormal_lacrimal_gland | 1.14653548 |
| 77 | MP0003075_altered_response_to | 1.14465724 |
| 78 | MP0002282_abnormal_trachea_morphology | 1.14262638 |
| 79 | MP0008057_abnormal_DNA_replication | 1.14007457 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 1.13717466 |
| 81 | MP0002405_respiratory_system_inflammati | 1.12288743 |
| 82 | MP0010368_abnormal_lymphatic_system | 1.11843861 |
| 83 | MP0003448_altered_tumor_morphology | 1.11448587 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.09892524 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.09519578 |
| 86 | MP0002249_abnormal_larynx_morphology | 1.09013430 |
| 87 | MP0005387_immune_system_phenotype | 1.07935161 |
| 88 | MP0001790_abnormal_immune_system | 1.07935161 |
| 89 | MP0000490_abnormal_crypts_of | 1.07741807 |
| 90 | MP0002398_abnormal_bone_marrow | 1.07729565 |
| 91 | MP0010094_abnormal_chromosome_stability | 1.05574311 |
| 92 | MP0000716_abnormal_immune_system | 1.05237713 |
| 93 | MP0001216_abnormal_epidermal_layer | 1.02569131 |
| 94 | MP0005666_abnormal_adipose_tissue | 1.02515083 |
| 95 | MP0000427_abnormal_hair_cycle | 1.01385831 |
| 96 | MP0004272_abnormal_basement_membrane | 1.00688019 |
| 97 | MP0005266_abnormal_metabolism | 1.00380897 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.00174509 |
| 99 | MP0001243_abnormal_dermal_layer | 0.99720541 |
| 100 | MP0003868_abnormal_feces_composition | 0.99101925 |
| 101 | MP0005367_renal/urinary_system_phenotyp | 0.98069116 |
| 102 | MP0000516_abnormal_urinary_system | 0.98069116 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.97772473 |
| 104 | MP0005164_abnormal_response_to | 0.95900523 |
| 105 | MP0004947_skin_inflammation | 0.95062627 |
| 106 | MP0008469_abnormal_protein_level | 0.94949963 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.94394488 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.94365067 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.91327805 |
| 110 | MP0000604_amyloidosis | 0.91146788 |
| 111 | MP0005310_abnormal_salivary_gland | 0.90155357 |
| 112 | MP0003186_abnormal_redox_activity | 0.90031243 |
| 113 | MP0002429_abnormal_blood_cell | 0.89915296 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.89574524 |
| 115 | MP0003279_aneurysm | 0.88790292 |
| 116 | MP0005508_abnormal_skeleton_morphology | 0.88499924 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.86720229 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.86038377 |
| 119 | MP0003690_abnormal_glial_cell | 0.85618969 |
| 120 | MP0003941_abnormal_skin_development | 0.85025180 |
| 121 | MP0005409_darkened_coat_color | 0.85003492 |
| 122 | MP0005365_abnormal_bile_salt | 0.82953473 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.82377564 |
| 124 | MP0002722_abnormal_immune_system | 0.81750726 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.81449395 |
| 126 | MP0010771_integument_phenotype | 0.80260515 |
| 127 | MP0000750_abnormal_muscle_regeneration | 0.78965669 |
| 128 | MP0001958_emphysema | 0.78779281 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.78613347 |
| 130 | MP0009931_abnormal_skin_appearance | 0.78437695 |
| 131 | MP0001764_abnormal_homeostasis | 0.77142033 |
| 132 | MP0008058_abnormal_DNA_repair | 0.77041910 |
| 133 | MP0005166_decreased_susceptibility_to | 0.75656548 |
| 134 | MP0000249_abnormal_blood_vessel | 0.74972299 |
| 135 | MP0009053_abnormal_anal_canal | 0.74828866 |
| 136 | MP0009763_increased_sensitivity_to | 0.74584215 |
| 137 | MP0005535_abnormal_body_temperature | 0.74392134 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.74274037 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.74185582 |
| 140 | MP0005257_abnormal_intraocular_pressure | 0.74158890 |
| 141 | MP0010307_abnormal_tumor_latency | 0.72308878 |
| 142 | MP0004883_abnormal_blood_vessel | 0.70146183 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.65762704 |
| 144 | MP0005647_abnormal_sex_gland | 0.64711437 |
| 145 | * MP0008874_decreased_physiological_sensi | 0.64301768 |
| 146 | MP0000749_muscle_degeneration | 0.62492462 |
| 147 | MP0000733_abnormal_muscle_development | 0.60644912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.17858718 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.17858718 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.17858718 |
| 4 | Thrombocytosis (HP:0001894) | 5.64730494 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.80833165 |
| 6 | Nuclear cataract (HP:0100018) | 4.65670623 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 4.22349262 |
| 8 | Myositis (HP:0100614) | 4.01495903 |
| 9 | Syringomyelia (HP:0003396) | 3.88952279 |
| 10 | Spinal cord lesions (HP:0100561) | 3.88952279 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.83886966 |
| 12 | Disinhibition (HP:0000734) | 3.82281988 |
| 13 | Axonal loss (HP:0003447) | 3.72388826 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.56129689 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.46516785 |
| 16 | Milia (HP:0001056) | 3.41191338 |
| 17 | Atrophic scars (HP:0001075) | 3.36665310 |
| 18 | Fragile nails (HP:0001808) | 3.36266397 |
| 19 | Petechiae (HP:0000967) | 3.35769951 |
| 20 | Loss of speech (HP:0002371) | 3.34351508 |
| 21 | Stomatitis (HP:0010280) | 3.31242769 |
| 22 | Abnormal number of erythroid precursors (HP:0012131) | 3.28459058 |
| 23 | Onycholysis (HP:0001806) | 3.21031284 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.20627773 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 3.20147719 |
| 26 | Orchitis (HP:0100796) | 3.13766261 |
| 27 | Glomerulonephritis (HP:0000099) | 3.10357257 |
| 28 | Asymmetry of the thorax (HP:0001555) | 3.05865138 |
| 29 | Complement deficiency (HP:0004431) | 3.02780609 |
| 30 | Missing ribs (HP:0000921) | 3.00087621 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97430383 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97430383 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97430383 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.96960810 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.96960810 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.96685442 |
| 37 | Myocardial infarction (HP:0001658) | 2.93790785 |
| 38 | Type I transferrin isoform profile (HP:0003642) | 2.91159117 |
| 39 | Nausea (HP:0002018) | 2.86988523 |
| 40 | Parakeratosis (HP:0001036) | 2.84988615 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.79926790 |
| 42 | Cutaneous melanoma (HP:0012056) | 2.78234301 |
| 43 | Periodontitis (HP:0000704) | 2.77084550 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.74534657 |
| 45 | Plantar hyperkeratosis (HP:0007556) | 2.72630059 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.68577603 |
| 47 | Intrahepatic cholestasis (HP:0001406) | 2.67605426 |
| 48 | Increased serum ferritin (HP:0003281) | 2.66938808 |
| 49 | Aplasia cutis congenita (HP:0001057) | 2.66404618 |
| 50 | Basal ganglia calcification (HP:0002135) | 2.64512498 |
| 51 | Vasculitis (HP:0002633) | 2.62472369 |
| 52 | Reticulocytopenia (HP:0001896) | 2.62202713 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.61159669 |
| 54 | White forelock (HP:0002211) | 2.59014324 |
| 55 | 11 pairs of ribs (HP:0000878) | 2.56775347 |
| 56 | Mutism (HP:0002300) | 2.55706258 |
| 57 | Eosinophilia (HP:0001880) | 2.55039186 |
| 58 | Thoracolumbar scoliosis (HP:0002944) | 2.53431082 |
| 59 | Aplastic anemia (HP:0001915) | 2.48099789 |
| 60 | Fragile skin (HP:0001030) | 2.45831504 |
| 61 | Patchy hypopigmentation of hair (HP:0011365) | 2.41333964 |
| 62 | Abnormality of complement system (HP:0005339) | 2.40966004 |
| 63 | Thick nail (HP:0001805) | 2.39926264 |
| 64 | Optic neuritis (HP:0100653) | 2.39490077 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.39490077 |
| 66 | Ureteral stenosis (HP:0000071) | 2.37991672 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37742339 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.36298795 |
| 69 | Skin ulcer (HP:0200042) | 2.32842969 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.32299031 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.32175457 |
| 72 | Ureteral obstruction (HP:0006000) | 2.31462590 |
| 73 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30774784 |
| 74 | Granulocytopenia (HP:0001913) | 2.28980896 |
| 75 | Arterial thrombosis (HP:0004420) | 2.28865372 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.25151169 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.23764432 |
| 78 | Abnormality of the pericardium (HP:0001697) | 2.20789448 |
| 79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17434742 |
| 80 | Amyloidosis (HP:0011034) | 2.17296976 |
| 81 | Dry hair (HP:0011359) | 2.17282455 |
| 82 | Thin bony cortex (HP:0002753) | 2.17068853 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16362473 |
| 84 | Obstructive lung disease (HP:0006536) | 2.16362473 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.15714425 |
| 86 | Abnormality of macrophages (HP:0004311) | 2.15683025 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.15655779 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.14656955 |
| 89 | Nephritis (HP:0000123) | 2.14540808 |
| 90 | Abnormality of the lumbar spine (HP:0100712) | 2.14294114 |
| 91 | Abnormality of the costochondral junction (HP:0000919) | 2.12709816 |
| 92 | Hyperparathyroidism (HP:0000843) | 2.12667094 |
| 93 | Ectropion (HP:0000656) | 2.12549147 |
| 94 | Pili torti (HP:0003777) | 2.12527206 |
| 95 | Increased IgM level (HP:0003496) | 2.12232014 |
| 96 | Protuberant abdomen (HP:0001538) | 2.10529851 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.10070924 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.09887821 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08999439 |
| 100 | Hematochezia (HP:0002573) | 2.08889960 |
| 101 | Chest pain (HP:0100749) | 2.08406247 |
| 102 | Polyneuropathy (HP:0001271) | 2.08397278 |
| 103 | Poor head control (HP:0002421) | 2.08157237 |
| 104 | Abnormal glycosylation (HP:0012345) | 2.08117202 |
| 105 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08117202 |
| 106 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08117202 |
| 107 | Abnormal protein glycosylation (HP:0012346) | 2.08117202 |
| 108 | Deep venous thrombosis (HP:0002625) | 2.07661021 |
| 109 | Gangrene (HP:0100758) | 2.07365290 |
| 110 | Autoimmune thrombocytopenia (HP:0001973) | 2.06649451 |
| 111 | Apathy (HP:0000741) | 2.05546205 |
| 112 | Severe visual impairment (HP:0001141) | 2.04508574 |
| 113 | Metaphyseal irregularity (HP:0003025) | 2.03116012 |
| 114 | Abnormal blistering of the skin (HP:0008066) | 2.02666928 |
| 115 | Leukocytosis (HP:0001974) | 2.02613515 |
| 116 | Zonular cataract (HP:0010920) | 2.02370211 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.01618363 |
| 118 | Sepsis (HP:0100806) | 2.01593402 |
| 119 | Abnormality of the nasal mucosa (HP:0000433) | 2.01420091 |
| 120 | Prolonged neonatal jaundice (HP:0006579) | 2.01100484 |
| 121 | Fused cervical vertebrae (HP:0002949) | 2.00768605 |
| 122 | Spondylolisthesis (HP:0003302) | 2.00506713 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.99204738 |
| 124 | Selective tooth agenesis (HP:0001592) | 1.98254293 |
| 125 | Hemoptysis (HP:0002105) | 1.97822980 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.96547878 |
| 127 | Hypoalphalipoproteinemia (HP:0003233) | 1.96419543 |
| 128 | Anhidrosis (HP:0000970) | 1.95720997 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.95193309 |
| 130 | Keratoconjunctivitis (HP:0001096) | 1.93821059 |
| 131 | Protrusio acetabuli (HP:0003179) | 1.93308877 |
| 132 | Cervical subluxation (HP:0003308) | 1.91954023 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.91486470 |
| 134 | Inappropriate behavior (HP:0000719) | 1.90868388 |
| 135 | Nail dystrophy (HP:0008404) | 1.90742540 |
| 136 | Rickets (HP:0002748) | 1.86494811 |
| 137 | Blepharitis (HP:0000498) | 1.86461677 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85706125 |
| 139 | Acute myeloid leukemia (HP:0004808) | 1.85236409 |
| 140 | Enlarged epiphyses (HP:0010580) | 1.84844518 |
| 141 | Epistaxis (HP:0000421) | 1.84496450 |
| 142 | Submucous cleft hard palate (HP:0000176) | 1.83641684 |
| 143 | Recurrent skin infections (HP:0001581) | 1.83563535 |
| 144 | Peritonitis (HP:0002586) | 1.82924951 |
| 145 | Upper motor neuron abnormality (HP:0002127) | 1.82648183 |
| 146 | Abnormality of eosinophils (HP:0001879) | 1.82534410 |
| 147 | Mesangial abnormality (HP:0001966) | 1.82369050 |
| 148 | Abnormality of the basal ganglia (HP:0002134) | 1.82275311 |
| 149 | Conical tooth (HP:0000698) | 1.81921258 |
| 150 | J-shaped sella turcica (HP:0002680) | 1.80732628 |
| 151 | Purpura (HP:0000979) | 1.80558985 |
| 152 | Diminished motivation (HP:0000745) | 1.80462088 |
| 153 | Abnormality of the pleura (HP:0002103) | 1.79649747 |
| 154 | Pustule (HP:0200039) | 1.79330042 |
| 155 | Aortic valve stenosis (HP:0001650) | 1.77899621 |
| 156 | Nasal polyposis (HP:0100582) | 1.77681442 |
| 157 | Joint stiffness (HP:0001387) | 1.77505664 |
| 158 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77402284 |
| 159 | Premature graying of hair (HP:0002216) | 1.76988137 |
| 160 | Vertigo (HP:0002321) | 1.76235016 |
| 161 | Anorexia (HP:0002039) | 1.76224683 |
| 162 | Glomerulopathy (HP:0100820) | 1.76163505 |
| 163 | Cellulitis (HP:0100658) | 1.76044521 |
| 164 | Short middle phalanx of the 5th finger (HP:0004220) | 1.74244894 |
| 165 | Vertebral compression fractures (HP:0002953) | 1.73716112 |
| 166 | Premature rupture of membranes (HP:0001788) | 1.72039832 |
| 167 | Malnutrition (HP:0004395) | 1.71744626 |
| 168 | Peripheral demyelination (HP:0011096) | 1.70141172 |
| 169 | Poikiloderma (HP:0001029) | 1.69995900 |
| 170 | Hypothermia (HP:0002045) | 1.69781712 |
| 171 | Achilles tendon contracture (HP:0001771) | 1.68029783 |
| 172 | Acne (HP:0001061) | 1.66295587 |
| 173 | Thoracic kyphosis (HP:0002942) | 1.64668788 |
| 174 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.63656012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.72982874 |
| 2 | GRK7 | 4.25425907 |
| 3 | PIM2 | 3.89509416 |
| 4 | RIPK1 | 3.48034470 |
| 5 | MOS | 3.12391527 |
| 6 | LATS2 | 2.61514132 |
| 7 | MAP3K14 | 2.59152071 |
| 8 | CDK8 | 2.47184421 |
| 9 | MKNK1 | 2.34720844 |
| 10 | NME2 | 2.29466929 |
| 11 | TBK1 | 2.25984993 |
| 12 | EIF2AK1 | 2.14906346 |
| 13 | IRAK4 | 2.11253971 |
| 14 | ERN1 | 2.10513614 |
| 15 | IRAK3 | 2.07004881 |
| 16 | NEK9 | 2.02316842 |
| 17 | MUSK | 2.01199054 |
| 18 | MAPKAPK5 | 1.90323889 |
| 19 | ERBB3 | 1.88133032 |
| 20 | RPS6KA4 | 1.81533040 |
| 21 | IKBKB | 1.81109805 |
| 22 | EIF2AK3 | 1.76066026 |
| 23 | TRPM7 | 1.75003921 |
| 24 | TYK2 | 1.73951835 |
| 25 | TAOK1 | 1.71058330 |
| 26 | MYLK | 1.70570317 |
| 27 | MAP3K12 | 1.70131158 |
| 28 | NUAK1 | 1.67951249 |
| 29 | KIT | 1.62077255 |
| 30 | BMPR1B | 1.60826684 |
| 31 | IKBKE | 1.60662360 |
| 32 | EPHA3 | 1.60208549 |
| 33 | TEC | 1.54951344 |
| 34 | MST4 | 1.54693624 |
| 35 | VRK1 | 1.50768784 |
| 36 | TGFBR1 | 1.48618996 |
| 37 | ZAK | 1.48291952 |
| 38 | MAP3K11 | 1.44885147 |
| 39 | PDGFRA | 1.43882370 |
| 40 | EIF2AK2 | 1.37764419 |
| 41 | PBK | 1.36943142 |
| 42 | CDC42BPA | 1.34566635 |
| 43 | PLK4 | 1.34029288 |
| 44 | ABL2 | 1.30563057 |
| 45 | SCYL2 | 1.29996556 |
| 46 | STK16 | 1.28655064 |
| 47 | PRPF4B | 1.27586721 |
| 48 | PIM1 | 1.26926260 |
| 49 | JAK3 | 1.22238590 |
| 50 | BTK | 1.21934201 |
| 51 | MAP3K5 | 1.20864659 |
| 52 | TXK | 1.16498593 |
| 53 | ILK | 1.16305267 |
| 54 | RPS6KB2 | 1.13872655 |
| 55 | TGFBR2 | 1.13828577 |
| 56 | CLK1 | 1.08575427 |
| 57 | MAP3K1 | 1.04666200 |
| 58 | BMPR2 | 1.04557291 |
| 59 | LRRK2 | 1.02049073 |
| 60 | CHUK | 0.98192898 |
| 61 | MATK | 0.97622562 |
| 62 | KDR | 0.97158287 |
| 63 | EEF2K | 0.90650928 |
| 64 | MAPKAPK3 | 0.87056241 |
| 65 | FRK | 0.86811961 |
| 66 | LATS1 | 0.86790856 |
| 67 | JAK1 | 0.81957012 |
| 68 | FGR | 0.81105228 |
| 69 | CSK | 0.80830009 |
| 70 | CSF1R | 0.79347240 |
| 71 | IRAK2 | 0.79161482 |
| 72 | BLK | 0.79085600 |
| 73 | TESK1 | 0.78202927 |
| 74 | CDK7 | 0.77857413 |
| 75 | LYN | 0.73932370 |
| 76 | TIE1 | 0.73785311 |
| 77 | TNIK | 0.73683995 |
| 78 | PKN2 | 0.71848581 |
| 79 | RAF1 | 0.70244632 |
| 80 | MAPK4 | 0.69358386 |
| 81 | DAPK3 | 0.68856319 |
| 82 | EPHB2 | 0.68506542 |
| 83 | STK10 | 0.68492355 |
| 84 | PIK3CG | 0.67901985 |
| 85 | TNK2 | 0.67091015 |
| 86 | PKN1 | 0.66894957 |
| 87 | FES | 0.66258549 |
| 88 | PAK4 | 0.65056399 |
| 89 | TLK1 | 0.64599207 |
| 90 | RPS6KA6 | 0.63739429 |
| 91 | RPS6KA5 | 0.63443288 |
| 92 | JAK2 | 0.63007993 |
| 93 | MARK3 | 0.62478088 |
| 94 | ATR | 0.62445453 |
| 95 | DYRK1B | 0.60178820 |
| 96 | GRK5 | 0.59572570 |
| 97 | ARAF | 0.59131296 |
| 98 | CDK6 | 0.58863530 |
| 99 | WEE1 | 0.58739134 |
| 100 | ABL1 | 0.58647748 |
| 101 | ICK | 0.57929943 |
| 102 | OBSCN | 0.57110552 |
| 103 | MAP3K13 | 0.55999360 |
| 104 | AURKB | 0.55826805 |
| 105 | SRPK1 | 0.54992019 |
| 106 | MAPKAPK2 | 0.54987318 |
| 107 | DYRK3 | 0.54276480 |
| 108 | SYK | 0.52419221 |
| 109 | MAP4K1 | 0.52141980 |
| 110 | RPS6KC1 | 0.52076937 |
| 111 | RPS6KL1 | 0.52076937 |
| 112 | BMX | 0.51358876 |
| 113 | YES1 | 0.51175553 |
| 114 | TTN | 0.50627570 |
| 115 | MAP3K3 | 0.49939398 |
| 116 | IRAK1 | 0.49904027 |
| 117 | AKT3 | 0.49253069 |
| 118 | PDGFRB | 0.48220613 |
| 119 | TAOK2 | 0.47169442 |
| 120 | MAP2K3 | 0.46927811 |
| 121 | ZAP70 | 0.46564654 |
| 122 | ADRBK2 | 0.46267999 |
| 123 | CAMKK2 | 0.45903095 |
| 124 | HCK | 0.45878972 |
| 125 | RIPK4 | 0.45867866 |
| 126 | PRKCD | 0.45829698 |
| 127 | BRAF | 0.44879183 |
| 128 | MKNK2 | 0.43224604 |
| 129 | NEK6 | 0.41710818 |
| 130 | INSRR | 0.41607657 |
| 131 | NLK | 0.40892569 |
| 132 | ACVR1B | 0.40416543 |
| 133 | GSK3A | 0.39526063 |
| 134 | TRIB3 | 0.39320341 |
| 135 | PAK2 | 0.39268193 |
| 136 | PDPK1 | 0.36487503 |
| 137 | PRKAA2 | 0.34923823 |
| 138 | CDK4 | 0.32284773 |
| 139 | HIPK2 | 0.31399037 |
| 140 | PAK1 | 0.30022421 |
| 141 | MAPK7 | 0.26536171 |
| 142 | MAP3K8 | 0.25286923 |
| 143 | PRKD2 | 0.24942553 |
| 144 | STK38 | 0.24355476 |
| 145 | RPS6KA2 | 0.21827187 |
| 146 | PLK2 | 0.21514490 |
| 147 | EGFR | 0.20967651 |
| 148 | TYRO3 | 0.20626996 |
| 149 | MAP2K6 | 0.19376446 |
| 150 | INSR | 0.18522663 |
| 151 | ROCK1 | 0.17518857 |
| 152 | PINK1 | 0.17311956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.23861052 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.91365174 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53431817 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39903603 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.27555031 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.16146306 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.13391769 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13339136 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09198148 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.09192045 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.08111907 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97976235 |
| 13 | Prion diseases_Homo sapiens_hsa05020 | 1.95985361 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.93445406 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87821336 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.80305759 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78017068 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.77942734 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76907279 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68791961 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68494486 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.60981913 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.60227767 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59866184 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59672365 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54349387 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51366646 |
| 28 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49697000 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49465936 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.48643572 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.46190181 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43624204 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.31606087 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30556662 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29740723 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.25744666 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23609021 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23405687 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21233158 |
| 40 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21179874 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20379910 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.20282429 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19571934 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.19022852 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18536754 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.16665284 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.16463105 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12686995 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12508246 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11310530 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.10765094 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.10460749 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10298353 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.06750086 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06715351 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06625685 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.05965731 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 1.05347498 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.03107985 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02288511 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02035927 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98233875 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97581832 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96482122 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.95811789 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94756368 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90581012 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89068833 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88854863 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88652925 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.87842148 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87748893 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.87389696 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86882479 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86801799 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86611276 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84152272 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83150844 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81138980 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80714814 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78648832 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.78049450 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76700447 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76392263 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74432790 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73988392 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73467924 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71608258 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69759296 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69299959 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67577389 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67174908 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63054551 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60925226 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59510754 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58231411 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56381387 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55603107 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54177261 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.53984287 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.52800071 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.52621108 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51707830 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51632066 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51016362 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50659984 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50262409 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49651710 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49332881 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48951965 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.48781996 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48585978 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48185853 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47045628 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45932358 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45930282 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44991272 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44735423 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.44696733 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43956951 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.42692208 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40535456 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39811068 |
| 124 | RNA transport_Homo sapiens_hsa03013 | 0.39235504 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38941189 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37200190 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35548348 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31929788 |
| 129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31245743 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30332115 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28539493 |
| 132 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28031629 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23650489 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22800422 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22307205 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21260665 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20437069 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.17647959 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17125273 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.16336201 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15902218 |

